Clicky

Dechra Pharmaceuticals PLC(1PK)

Description: Dechra Pharmaceuticals PLC develops, manufactures, regulates, markets, and sells veterinary pharmaceuticals and related products for veterinarians. It operates through three segments: European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals Research and Development. The company offers various endocrinology, dermatology, analgesia and anesthesia, cardiovascular, and critical care products for dogs and cats; water soluble antibiotics, poultry vaccines, and pain management for poultry, pigs, and cattle; and lameness and pain management products for horses and ponies. It also provides pet nutrition products for supporting cats and dogs with various therapeutic conditions, such as allergies, obesity, heart, and kidney diseases. In addition, the company distributes veterinary pharmaceuticals and equipment; offers financial services; markets pet diets; and develops, regulates, manufactures, and markets crop protection. It markets its products through wholesaler and distributor networks. The company operates in the United Kingdom, Germany, rest of Europe, the United States, and internationally. Dechra Pharmaceuticals PLC was incorporated in 1997 and is headquartered in Northwich, the United Kingdom.


Keywords: Pain Antibiotics Pain Management Obesity Kidney Disease Care Products Allergies Offers Financial Services Veterinary Pharmaceuticals Pain Management Products Pet Nutrition Products Dechra Pharmaceuticals

Home Page: www.dechra.com

24 Cheshire Avenue
Northwich, CW9 7UA
United Kingdom
Phone: 44 1606 814730


Officers

Name Title
Mr. Ian D. Page CEO, MD & Exec. Director
Mr. Paul Nicholas Sandland MAAT, FCCA CFO & Exec. Director
Dr. Anthony Gerard Griffin MD of Dechra Veterinary Products for Europe & Exec. Director
Mr. Patrick Meeus Group Scientific Officer
Ms. Katy Clough Group HR Director
Mr. Mike Eldred Pres of North America
Ms. Melanie Hall Company Sec.

Exchange: F

Country: DE

Currency: Euro (€)

Forward PE: 23.3645
Trailing PE: 49.1803
Price-to-Book MRQ: 4.7226
Price-to-Sales TTM: 5.2562
IPO Date:
Fiscal Year End: June
Full Time Employees: 1998
Back to stocks